Merck KGaA ADR (MKKGY)
Merck KGaA ADR is a depositary receipt representing common stock of Merck KGaA, a science and technology company headquartered in Darmstadt, Germany, and listed on OTC Markets. Through its operating businesses, Merck KGaA serves customers across Europe, North America, Latin America, the Middle East and Africa, and the Asia Pacific region. Its Life Science segment supplies products, tools, and services for research, testing, and bioprocessing applications, while the Healthcare segment develops, manufactures, and markets prescription medicines and biopharmaceuticals in areas including oncology, rare diseases, neurology, immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment focuses on materials and solutions used in semiconductor and display-related applications. Founded in 1668, Merck KGaA is a subsidiary of E. Merck KG.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-MKKG.Y
|
$34.15
|
11.4% Upside
|
Fair
|
$34.04
|
11.1% Upside
|
Fair
|
Good
|
—
|
—
|
0.35
|
1.1%
|
August 6, 2026
|
23.2x
|
2.0x
|
2.8x
|
67.017 B
|
76.404 B
|
17.0%
|
29.7%
|
9.7
|
39.8%
|
104.4%
|
